Background-Nitric oxide (NO) has been implicated as a mediator of "second-window" ischemic preconditioning, and mitochondrial ATP-dependent K ϩ (mitoK ATP ) channels are the likely effectors. The links between NO and mitoK ATP channels are unknown. Methods and Results-We measured mitochondrial redox potential as an index of mitoK ATP channel opening in rabbit ventricular myocytes. The NO donor S-nitroso-N-acetyl-DL-penicillamine (SNAP, 0.1 to 1 mmol/L) oxidized the mitochondrial matrix dose-dependently without activating sarcolemmal K ATP channels. SNAP-induced oxidation was blocked by the selective mitoK ATP channel blocker 5-hydroxydecanoate and by the NO scavenger 2-(4-carboxyphenyl)-4,4Ј,5,5Ј-tetramethylimidazole-1-oxyl-3-oxide. SNAP-induced mitochondrial oxidation was detectable either by photomultiplier tube recordings of flavoprotein fluorescence or by confocal imaging. SNAP also enhanced the oxidative effects of diazoxide when both agents were applied together. Exposure to 1 mmol/L 8Br-cGMP failed to mimic the effects of SNAP. Conclusions-NO directly activates mitoK ATP channels and potentiates the ability of diazoxide to open these channels. These results provide novel mechanistic links between NO-induced cardioprotection and mitoK ATP channels. (Circulation.
N itric oxide is a key signaling molecule that figures prominently in ischemic preconditioning. NO is generated during the oxidation of L-arginine to citrulline, not only in the cytosol but also in mitochondria. [1] [2] [3] During ischemia, the endogenous production of NO in the heart is increased. 1 It is also common therapeutic practice to administer exogenous nitrates in acute ischemic syndromes, further boosting the concentration of NO. Although NO has been reported to afford cardioprotection from reperfusion injury, 4 -6 the role of NO during the early phase of ischemic preconditioning is controversial. [7] [8] [9] [10] Conversely, several lines of evidence convincingly implicate NO as a mediator of the late phase (second window) of ischemic preconditioning against infarction and stunning. [11] [12] [13] The cardioprotective effects of NO have been explained by several factors, such as microvascular effects, 4 antineutrophil action, 4 induction of stress protein, 14 or modulation of cardiac excitability. 7 Recently, Bernardo et al 15 reported that delayed ischemic preconditioning is inhibited by 5-hydroxydecanoate (5HD) in the rabbit heart. Because 5HD is a selective blocker of mitochondrial ATP-dependent potassium (mitoK ATP ) channels in rabbit ventricular cells, 16 the ability of 5HD to abolish secondwindow protection motivated us to look for possible links between NO and mitoK ATP channels.
Methods

The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication 85-23, revised 1985).
Materials
Collagenase (type II) was purchased from Worthington. Diazoxide, 2,4-dinitrophenol (DNP), sodium cyanide (CN), SNAP, and 8-bromo cGMP (8Br-cGMP) were obtained from Sigma Chemical Co. 5HD, pinacidil, and 2-(4-carboxyphenyl)-4,4Ј,5,5Ј-tetramethylimidazole-1-oxyl 3-oxide (carboxy-PTIO) were purchased from Research Biochemical International. Diazoxide, SNAP, pinacidil, and carboxy-PTIO were dissolved in DMSO before they were added to experimental solutions. The final concentration of DMSO was Ͻ0.1%.
Cell Isolation and Measurement of Mitochondrial Redox State
Rabbit ventricular myocytes were isolated enzymatically from adult rabbit hearts and placed in primary culture as described previously. 16, 17 Experiments were performed over the next day. MitoK ATP channel activity was monitored noninvasively by measuring flavoprotein fluorescence as an index of mitochondrial redox state with or without simultaneous whole-cell membrane current recordings (as indicated). 16 -18 Cells were superfused with external solution containing (in mmol/L) NaCl 140, KCl 5, CaCl 2 1, MgCl 2 1, and HEPES 10 (pH adjusted to 7.4 with NaOH) at room temperature (Ϸ22°C). Endogenous flavoprotein fluorescence was excited for 100 ms every 6 seconds by a xenon arc lamp with a bandpass filter centered at 480 nm. Emitted fluorescence was recorded at 530 nm by a photomul-tiplier tube and digitized. The redox signal was averaged during the excitation window and calibrated at the end of each experiment by exposure to DNP, which uncouples respiration from ATP synthesis and induces maximal oxidation. Therefore, the values of flavoprotein fluorescence are expressed as a percentage of the DNP-induced fluorescence. Individual myocytes were observed with a ϫ40 objective to monitor fluorescence 1 cell at a time.
Confocal Imaging of Flavoprotein Fluorescence
Confocal images were obtained with a Diaphot 300 inverted fluorescence microscope with a PCM-2000 confocal scanning attachment (Nikon, Inc). 17, 18 Fluorescence was excited by the 488-nm line of an argon laser, and the emission at 505 to 535 nm was recorded. A time series of images was collected at intervals of 10 seconds, and baseline, diazoxide, SNAP, SNAPϩ5HD, CN, and DNP images were enhanced by averaging of 7 sequential images having stable mean fluorescence intensities during exposure to each agent. Images were analyzed on a personal computer with the software program Simple32 (Compix, Inc).
Data Analysis
To evaluate the effects of pharmacological agents on flavoprotein fluorescence, the slope of relative change in the fluorescence during drug application was calculated by a least-squares method. The best-fit line is indicated by a dotted line in Figure 1 
Electrophysiological Recordings
In some experiments (Figure 3 ), whole-cell currents and flavoprotein fluorescence were measured simultaneously. The internal pipette solution contained (in mmol/L) potassium glutamate 120, KCl 25, MgCl 2 0.5, K-EGTA 10, HEPES 10, and MgATP 1 (pH adjusted to 7.2 with KOH). Whole-cell currents were elicited every 6 seconds from a holding potential of Ϫ80 mV by 2 consecutive steps to Ϫ40 mV (for 100 ms) and 0 mV (for 380 ms), and flavoprotein fluorescence was excited during the 100-ms step to Ϫ40 mV. To quantify I K,ATP , currents at 0 mV were measured 200 ms into the pulse. Figure 1A shows the time course of flavoprotein fluorescence in a cell exposed first to diazoxide, then to SNAP, and finally again to diazoxide. In the first application, diazoxide reversibly oxidized the flavoproteins. Subsequent exposure to SNAP alone gradually increased flavoprotein oxidation with a slope of 0.59%/min. After a 15-minute exposure to SNAP, mitochondrial oxidation persisted even 5 minutes after washout. Although NO has been reported to inhibit respiration, 2, 19, 20 the present changes are in the opposite direction to those that would be expected from such an effect (in which case the mitochondrial matrix would have been reduced, as it is with CN Ϫ ). 18 Note also that the second exposure to diazoxide after SNAP increased flavoprotein oxidation above the levels reached in the first application, with less of a lag during the second exposure (4 minutes, versus 8 to 9 minutes during the first exposure).
Results
Effects of SNAP on mitoK ATP Channels
To determine whether mitoK ATP channels are involved in SNAPinduced mitochondrial oxidation, we applied 5HD, a selective mitoK ATP channel blocker. Figure 1 , B and C, shows that 1 mmol/L 5HD reversed (B) or prevented (C) the SNAP-induced flavoprotein oxidation. Figure 1D summarizes the amplitude of diazoxideinduced flavoprotein oxidation during the first [DIAZO(1)] and second exposures to diazoxide after the application of SNAP [DIAZO(2) SNAP]. Pretreatment with SNAP significantly enhanced the effects of diazoxide-induced oxidation; we have previously shown that repeated exposures to diazoxide alone do not produce potentiation. 17 Figure 1E summarizes the latency to mitoK ATP channel activation, measured as the time required to increase flavoprotein fluorescence to 20% of its maximal value after washing in diazoxide. The latency was significantly abbreviated during the second exposure to diazoxide after SNAP. Figure 1F summarizes the effects of 5HD on the SNAP-induced fluorescence changes and verifies that 5HD significantly and consistently inhibits SNAPinduced mitochondrial oxidation. These results indicate that SNAPinduced mitochondrial oxidation is mediated by activation of mitoK ATP channels.
Effects of SNAP on Flavoprotein Fluorescence Detected by Confocal Imaging
To further confirm the NO-induced activation of mitoK ATP channels, the effect of SNAP on flavoprotein fluorescence was measured by confocal imaging. Fluorescence was low under control conditions (Figure 2A ), but exposure to diazoxide reversibly increased fluorescence (B; washout image in C). Subsequent exposure to SNAP also increased flavoprotein fluorescence (D), but SNAP-induced oxidation was inhibited by additional application of 5HD (E). Images were calibrated at the end of the experiment by exposure to cyanide (F) and DNP (G). The patchy distribution of fluorescence in the confocal images is typical of mitochondria, 17, 18 confirming that NO oxidizes the mitochondrial matrix by activation of mitoK ATP channels.
Effects of SNAP on mitoK ATP and Sarcolemmal K ATP Channels
To test the selectivity of NO on mitoK ATP versus sarcolemmal K ATP channels, we examined the effects of SNAP on flavoprotein fluorescence and whole-cell currents simultaneously. In Figure 3 , application of 0.5 mmol/L SNAP without preexposure to diazoxide gradually oxidized the mitochondrial matrix with a slope of 0.78%/min. SNAP-induced oxidation was inhibited by coapplication of 1 mmol/L 5HD. In the continued presence of 5HD, subsequent exposure to 100 mol/L pinacidil (a mixed mitoK ATP /surface K ATP agonist) 16 failed to induce mitochondrial oxidation. In contrast, Figure 3 (bottom) shows that SNAP had no effect on sarcolemmal K ATP channels, because pinacidil activated sarcolemmal K ATP channels despite the presence of 5HD. These results are representative and reproducible. A 20-minute exposure to SNAP (0.5 mmol/L) had no significant effect on whole-cell current (before, 5.6Ϯ6.1 pA versus after, 12.9Ϯ4.8 pA at 0 mV, nϭ4, PϭNS). Nevertheless, in the presence of 1 mmol/L 5HD, a 10-minute exposure to 100 mol/L pinacidil increased sarcolemmal K ATP current (554.9Ϯ82.9 pA at 0 mV, nϭ4, PϽ0.001 versus before). These results indicate that SNAP selectively activates mitoK ATP channels. Furthermore, Figure  3 demonstrates that SNAP-induced activation of mitoK ATP channels does not require preexposure to diazoxide. Finally, the finding that 5HD suppresses the mitochondrial oxidation induced by pinacidil, but not the agonist effect on I K,ATP , demonstrates that 1 mmol/L 5HD is a selective inhibitor of mitoK ATP channels in rabbit ventricular cells. 16, 17 
Mediation by NO Independent of cGMP
To verify that the SNAP-induced changes are actually mediated by the release of NO, we tested the effects of carboxy-PTIO, an NO scavenger, 21 on the SNAP-induced flavoprotein oxidation. Figure 4A shows that coapplication of carboxy-PTIO with SNAP prevented the flavoprotein oxidation (slope Ͻ0%/min). Because many (but not all) of the effects of NO occur via a cGMP-dependent pathway, 22, 23 we tested whether NO-induced activation of mitoK ATP is mimicked by 8Br-cGMP. Figure 4B shows that exposure to this cell-permeable cGMP analogue did not increase flavoprotein oxidation, nor did pretreatment with 8Br-cGMP enhance diazoxide-induced oxidation. The effects of the NO scavenger and 8Br-cGMP were observed reproducibly. Figure 4 , C and D, shows that carboxy-PTIO abolished the enhancing effects of SNAP on diazoxide-induced oxidation, confirming that the SNAPinduced change is mediated by release of NO. Figure 4 , E and F, summarizes data for 8Br-cGMP, confirming that it fails to mimic the effects of SNAP.
The pooled data in Figure 5 reveal that SNAP significantly increases the slope of percent change in flavoprotein oxidation and that the SNAP-induced effect is inhibited by 5HD and carboxy-PTIO. The inset shows the dose-response relationship between SNAP concentration and flavoprotein oxidation. Taken together with the results in Figure 4 , these experiments support the idea that SNAP activates mitoK ATP channels dose-dependently via a direct effect of NO, not mediated by cGMP.
Effects of SNAP in the Presence of Diazoxide
We previously reported that protein kinase C (PKC) activation enhances diazoxide-induced changes without affecting basal flavoprotein fluorescence. 16 This finding indicates that the modulation of mitoK ATP by PKC may depend on whether the channels are in the open or closed state when the kinase becomes active. To test for analogous state-dependent changes in the case of NO, we quantified the effects of SNAP on channels that had already been opened by diazoxide. Figure 6A shows that 1 mmol/L SNAP rapidly enhanced diazoxide-induced oxidation when applied after the effect of diazoxide had reached steady state. Note that in this case, the effects of SNAP were reversible. Figure 6C shows that carboxy-PTIO abolished the enhancing effect of SNAP on diazoxide-induced oxidation, and Figure 6E demonstrates that 8Br-cGMP failed to mimic the effects of SNAP on mitoK ATP in the presence of diazoxide. Figure 6 , B, D, and F, summarizes data for coadministration of diazoxide with SNAP, SNAPϩcarboxy-PTIO, and 8Br-cGMP, respectively. These results indicate that NO enhances mitoK ATP channels preactivated by diazoxide. Channels that are already open appear to be more susceptible to the potentiating actions of NO than channels that are in the closed state.
Discussion
Our data reveal that NO selectively activates mitoK ATP channels but not sarcolemmal K ATP channels. The modulation of mitoK ATP channels by NO is manifested in 2 ways. One is the gradual oxidation induced by NO alone, and the other is potentiation of mitoK ATP channels preopened by diazoxide. The latter effect resembles that of phorbol esters that turn on PKC and enhance diazoxide-induced oxidation, 16 but unlike NO, phorbol esters alone do not suffice to activate the channels. It is possible that the 2 observations share a common pathway, inasmuch as reactive oxygen species (such as the NO product peroxynitrite) are known to activate PKC. 13, 24, 25 Shinbo and Iijima 26 reported that the application of the NO donor NOR-3 increased the open probability of agonist-activated surface K ATP channels in cardiac myocytes, whereas NOR-3 had no effect in the absence of channel agonists. We have found that PKC primes ventricular surface K ATP channels to open in response to agonists or to metabolic inhibition, but basal activity is unaffected. 27, 28 These findings again resemble the rapid enhancement of mitoK ATP by NO in the presence of diazoxide but differ in the inability of the modulator to alter basal activity. Although the structural relationship between surface and mitoK ATP channels is unknown, 29 the results suggest that the 2 channels may share regulatory pathways sensitive to NO, as is the case for PKC. 16, 27, 29 In pancreatic ␤ cells, NO has been argued to inhibit glycolysis, leading to a secondary activation of surface K ATP channels. 30 However, SNAP did not increase whole-cell K ATP current in the present study, consistent with the finding that NO alone did not activate single K ATP channels in cell-attached mode in guinea pig ventricular myocytes. 26 The mitoK ATP channel is not especially sensitive to changes in bulk [ATP], remaining closed even at 0.5 mmol/L [ATP]. 31 Considering these observations, it seems unlikely that the effects of NO on mitoK ATP channels reflect inhibition of glycolysis.
Both NO and mitoK ATP channels have been implicated in the delayed phase of preconditioning known as the "second window" of protection. [11] [12] [13] MitoK ATP channel opening is cardioprotective during ischemia, 17, 32 whereas blockade of mitoK ATP channels abolishes both classic and second-window protection. The present study establishes NO as an endogenous mitoK ATP channel opener that may be able to recruit cardioprotection in the second window. NO may play a particularly prominent role in the second window because of changes in gene expression, notably the upregulation of nitric oxide synthase that occurs within 24 hours of conditioning ischemia. Although the relationships between mitoK ATP channel activation and cardioprotection remain elusive, the opening of channels in the inner membrane may dissipate the mitochondrial potential established by the proton pump, perhaps blunting the Ca 2ϩ overload that would otherwise occur as a result of the large driving force for Ca 2ϩ entry into mitochondria during ischemia. 16, 17 It was recently reported that mitoK ATP channel openers release Ca 2ϩ from Ca 2ϩ -loaded mitochondria. 33 The uncoupling by diazoxide appears to be much gentler than that which can be induced by agents such as DNP 34 ; indeed, severe uncoupling should be harmful to myocytes, because energy production is critically reduced. We speculate that NO, functioning as an endogenous mitoK ATP channel opener, may titrate the coupling level of the mitochondria to an optimum that blunts mitochondrial calcium overload without significantly undermining ATP synthetic capacity.
